The U.S. government has given Gilead Sciences substantial funding to develop Covid-19 related products. Here, Donna Meyer In this episode, Julie Gerberding, M.D., Chief Executive Officer for the Foundation for the National Institutes of Health speaks with
The Mechanics of Pharma M&A with Gilead's Devang Bhuta: Bhuta, Gilead's SVP of corporate development, sits down with Painting the Art of the Possible with Brad D. Smith
Mingle Media TV and Red Carpet Report host, Linda Antwi, were invited to cover the 44th NAACP Image Awards Pre-Gala James Sapirstein, President and CEO at AzurRx BioPharma CBS Board weighs future of Leslie Moonves
Newsupdate Live #LiveStream #NewsNow | GENEVA - Briefing with ceos of major pharmaceuticals on drugs in the pipeline Gilead Sciences, and Blueprint Medicines. Sam_Kintz photo. Sam Kintz, MBA. Co-founder, Chief Executive Officer, and Member of the Board of Directors. Joe Gilead Sciences, Inc. - Governance - Board of Directors
Corporate Leadership Roundtable - June 2, 2021 Grand Keynote at TiEcon 2021 with Gilead Chairman and CEO, Daniel O'Day and Rich Karlgaard conversation about Innovating
Black Women Leaders: A Competitive Advantage This coronavirus drug seems promising. Ana Kasparian and John Iadarola discuss on The Young Turks. Keep Hope (and TYT) Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company's Board of Directors.
Deborah Gordon from the HBA Global Board of Directors interviews Devi SenGupta, Gilead. #HBAWOTY24 #HBAimpact. 2021 WBC Summit Breakout Session: Women's Leadership in Healthcare Deepening the U.S.-India Commercial Partnership: Make in India Campaign
uesday, November 18, 2025. Digital Press Briefing on breakthrough HIV drug Lenacapavir's Delivery and the America First Global N. Anthony Coles, MD Chairman & CEO, Onyx Pharmaceuticals Dr. Coles joined Onyx in March 2008 as President and Chief PWN: 10 Years Fierce
Leadership | Board of Directors | Scientific Advisors | Enliven Welcome to this special mash-up episode, where Shellye Archambeau, Former CEO, MetricStream, Advisor & Author, Deborah H. Gilead Sciences Chairman of the Board & CEO John Martin, Ph.D., discusses HIV treatment innovation and the the potential
Daniel P. O'Day, Chairman and Chief Executive Officer, Gilead Sciences, Inc. Jacqueline K. Barton, PhD, Jacqueline K. Barton, PhD, Professor Emerita, Video Breif : Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that
TiEcon 2023 Grand Keynote: Joydeep Ganguly, Gilead, & Mohan Giridharadas, LeanTaaS Gilead Sciences, Inc. As part of her appointment to the Board of members of our board of directors, specifically Ms. Tomasello, and We are happy to welcome John Cogan, a Senior Fellow at the Hoover Institution, to The Hamilton Review Podcast!
Global Virus Network (GVN) Adds Gilead Sciences to GVN FBN's Charlie Gasparino with the latest on the CBS investigation into sexual misconduct allegations against CEO Leslie Moonves. Gilead Sciences Board of Directors
Connect17 - Pt. 2 of 2 Box CEO Aaron Levie on Starboard proxy fight: Happy overall with relationship
Jean-Jacques Bienaimé Chief Executive Officer, BioMarin Mr. Bienaimé joined BioMarin in May 2005 as chief executive officer Kelsey Louie presents Impact Award to Patrick McGovern Digital Press Briefing: First Lenacapavir Delivery in Africa
Janice is joined by Robin Washington, Board director of Alphabet, Inc., Honeywell International Inc., Mastercard Foundation, Cabaletta Bio Appoints Global Commercial Leader Shawn
Board of Directors | Gilead How Women Can Become Board Members | Deborah H. Telman, EVP, Corp. Affairs, Gilead Sciences, Inc.
Ample research shows that companies with diverse boards are more innovative and higher performing. Get an inside look at one N. Anthony Coles, MD, Chairman & CEO, Onyx Pharmaceuticals, Inc. Our Board of Directors oversees the management and risks of our business and is responsible for upholding all our corporate values of integrity, inclusion,
John Martin The Challenges of Drug Development During COVID-19 Connect17 - Pt. 1 of 2
Gilead Sciences, Inc. - Gilead Sciences Announces 2.6 Percent Board of Directors and Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the AMGEN Ventures and Business Development in Los Angeles
PDA West Coast Chapter: 2024 Wrapped Diversity in the C-Suite | Shellye Archambeau, Deb Telman, & Fawn Lopez Welcome to THE JUNGLE – the wild and exciting world of business. The second episode in the COVID-19 series features a
The Mechanics of Pharma M&A with Devang Bhuva, SVP, Corporate Development at Gilead Sciences About This Episode Brad D. Smith, Executive Chairman of the Board of Intuit shares his lessons in leadership and the role of a TiEcon 2023 at Santa Clara Convention Center, May 3-5 Day 2 Grand Keynote: Joydeep Ganguly, Senior Vice President,
2024 HBA Woman of the Year Red Carpet Interview with Devi SenGupta Board and staff of Positive Women's Network USA reflect on our origins, growth, and future after 10 years of power.
Seeding and Supporting Early-Stage Biotech Companies with Xontogeny CEO Chris Garabedian Committee Composition - Gilead Sciences, Inc. - Governance Gilead beats, announces CEO stepping down
#BreakingNow | Briefing by pharma CEOs on #COVID19 drugs, organised by #IFPMA | 03-09-20 Board of Directors · Daniel O'Day · Jacqueline K. Barton, PhD · Jeffrey A. Bluestone, PhD · Sandra J. Horning, MD · Kelly A. Kramer · Ted W. Love, MD · Harish Manwani.
Session 2: CEO Perspectives othe Economy John C. Martin, PhD, Chairman and CEO, Gilead Sciences and Meg Whitman, Women comprise 80% of the healthcare workforce but only about 20% of the leadership positions across healthcare industries. CNBC's Meg Tirrell reports the latest on Gilead's quarterly earnings amid the CEO's announcement he's stepping down.
Hear from Steve Sitto Associate Director, Global Travel, Meetings, & Events, Gilead Sciences running for GBTA President - Board Full Show - "Connect17" Series Keys to the Boardroom, Hosted by Gilead #BEWPS
The College of Computer and Mathematical and Natural Sciences in collaboration with the University of Maryland Alumni Hear from Steve Sitto Welcome to the Connect17 Conference, Disruptive Technologies that Impact our Communities. Speakers: Kacy Hutchison Vice
Kelsey Louie, CEO of GMHC, presents the 2016 Harlem United Impact Award to Patrick McGovern, Senior Director of Government In this heartfelt episode of The Patient From Hell, host Samira Daswani talks to Jill Massey, a pharmacist and pharma industry
John Bryant – Former Chairman and CEO of Kellogg's | THE JUNGLE #2 The women behind accelerating Black female leaders into board seats, Black Women on Boards, visits the NYSE to talk more The Hamilton Review Ep. 208: John Cogan on the National Debt Crisis Plaguing our Country
Promising Coronavirus Treatment On The Way? Gillead CEO John Martin on the value CHI delivers for his company and the entire California biomedical community. Gilead Sciences CEO John Martin, Ph.D., on HIV Treatment Innovation & Healthcare Reform
Gilead CEO John Martin, PhD The company's Board of Directors has declared an increase of 2.6% in the company's quarterly cash dividend, beginning in the first quarter of 2025. Box CEO Aaron Levie joins 'Tech Check' to discuss the Starboard Ventures proxy fight and how it has changed the company.
At "Connect," we explore of how technologies continue to shape our society by focusing on social impact and beneficial use. Daniel O'Day of Gilead Sciences Becomes New Chair of PhRMA
Donna Meyer #AsksTheCEO of Gilead to Factor in Public Investment into Covid-19 Vaccine Pricing On June 2, we hosted an impactful roundtable discussion with Bay Area leaders to tackle the future of work in an evolving world. In May 2022, an outbreak of monkeypox, a viral disease, was confirmed. It quickly spread from the United Kingdom to many
Part 1 - "Connect17" Series Rosalyn M. Brock, Chairman of the Board, NAACP at 44th NAACP Image Awards Pre-Show Gala
Where Courage Stems From as a Minority | Deb Telman, EVP, Corp. Affairs, Gilead Sciences, Inc. John C. Martin, Ph.D. Chairman of the Board and Chief Executive Officer. Grand Keynote I Daniel O'Day, Gilead Sciences Inc and Rich Karlgaard I TiEcon 2021
James Sapirstein has served over thirty-five years in the pharmaceutical industry. He is currently the President and CEO of AzurRx Monkeypox: The Response and What's Next Wrapped is here. Check out some of our chapter's favorite moments from 2024! PDA WCC Board Officers: Stephanie Lee, Yashu
The Southern AIDS Coalition (SAC) initially launched SPARK! (Southerners Promoting Awareness, Resources & Knowledge) in Board of Directors. Albert Bourla of Pfizer and Paul Hudson of Sanofi also assumed new leadership positions on the PhRMA board. "PhRMA and SAC Spotlight on PPN v6
Merline Saintil & Robin Washington from Black Women on Boards joins NYSE TV Anthony Welters Joins Gilead Sciences' Board of Directors Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin Pharmaceutical Inc.
Gilead Science | Covid -19 Treatment | CEO Daniel O' Day Speech | Pharma Industry If you're ready to make an impact on a larger scale, come hear what it takes to serve on a corporate board and how to best In this episode, Mark talks with Chris Garabedian, Chairman and CEO of Xontogeny, which he founded in 2016 to support multiple
2:30 pm Panel: Make in India Campaign Hon. B.J. Panda Member of Parliament, Biju Janata Dal (BJD) Party Joseph Alhadeff Health Equity & Innovation: A Case Study on Importance of Board Diversity How much bioscience business development is really happening in Los Angeles? MODERATOR: Rajit Malhotra, Executive
John C Martin and Meg Whitman -- SIEPR Economic Summit 2012 How Women Can Become Board Members | Deb Telman, EVP, Corporate Affairs, Gilead Sciences, Inc. Committee Composition · Lead Independent Director · Board Chair · Committee Member · Committee Chair.
Patient from Hell Ep 79: Navigating Life's Curveballs: From Caregiver to Cancer Survivor